On the opinion of the European Commission "Scientific Committee on Food" regarding the tolerable upper intake level of vitamin E (2003)

European Journal of Nutrition

Volumn 44, Issue 1, 2005, Pages 60-62

  Azzi, Angelo ^a   Brigelius Flohé, Regina ^b   Kelly, Frank ^c   Lodge, John K ^d   Özer, Nesrin ^e   Packer, Lester ^f   Sies, Helmut ^g  

^a UNIVERSITY OF BERN   (Switzerland)

^b GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF SURREY   (United Kingdom)

^e MARMARA UNIVERSITY   (Turkey)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; BETA CAROTENE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; WARFARIN;

ABDOMINAL CRAMP; ALZHEIMER DISEASE; ANGINA PECTORIS; ANTICOAGULANT THERAPY; ATHEROSCLEROSIS; BLOOD ANALYSIS; BLOOD CELL COUNT; BLOOD CHEMISTRY; BLOOD CLOTTING; CARDIOVASCULAR RISK; CLINICAL OBSERVATION; CLINICAL TRIAL; DIARRHEA; DRUG TOLERABILITY; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEALTH CARE ORGANIZATION; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INCIDENCE; INGESTION; INSULIN DEPENDENT DIABETES MELLITUS; LABORATORY TEST; LETTER; MEDICAL EXPERT; METHODOLOGY; MORTALITY; POPULATION RESEARCH; PROTHROMBIN TIME; SCIENCE; SENESCENCE; SMOKING; STANDARD; STROKE; TOXICITY; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

ADVISORY COMMITTEES; ANTIOXIDANTS; CEREBROVASCULAR ACCIDENT; DOSE-RESPONSE RELATIONSHIP, DRUG; EUROPE; HUMANS; INTRACRANIAL HEMORRHAGES; VITAMIN E;

EID: 13844275266     PISSN: 14366207     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00394-005-0549-8     Document Type: Letter

References (15)

1. Anderson TW, Reid DBW (1974) A double-blind trial of vitamin E in angina pectoris. Am J Clin Nutr 27:1174-1178
2. Bierenbaum ML, et al. (1985) The effect of supplemental vitamin E on serum parameters in diabetics, postcoronary and normal subjects. Nutr Res Int 31: 1171-1180
3. Bursell SE, et al. (1999) High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care 22:1245-1251
4. FSA (Food Standards Agency) (2003) Expert Group on Vitamins and Minerals. Risk assessment of vitamin E, pp 145-154
5. Gillilan RE, et al. (1977) Quantitative evaluation of vitamin E in the treatment of angina pectoris. Am Heart J 93: 444-449
6. Heart Protection Study Collaborative Group (2002) MRC/BHF Heart protection study of antioxidant vitamin supplementation in 20.536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360:23-32
7. Kim JM, White RH (1996) Effect of vitamin E on the anticoagulant response to warfarin. Am J Cardiol 77:545-546
8. Leppälä JM, et al. (2000a) Controlled trial of a-tocopherol and b-carotene supplements on stroke incidence and mortality in male smokers. Arterioscler Thromb Vasc Biol 20:230-235
9. Leppäla JM, et al. (2000b) Vitamin E and beta carotene supplementation in high risk for stroke. A subgroup analysis of the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Arch Neurol 57:1503-1509
10. Meydani SN, et al. (1998) Assessment of the safety of supplementation with different amounts of vitamin E in healthy older adults. Am J Clin Nutr 68:311-318
11. Primary Prevention Project (2001) Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Lancet 357: 89-95
12. Sano M, et al. (1997) A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med 336:1216-1222
13. SCF (Scientific Committee on Food) (2003) Opinion of the Scientific Committee on Food on the Tolerable Upper Intake Level of Vitamin E
14. Stephens NG, et al. (1996) Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347:781-786
15. Yusef S, et al. (2000) Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes prevention Evaluation Study Investigators. N Engl J Med 342:154-160